It is diagnosed according to the Canadian consensus criteria, at least 6 months after onset when the following symptoms are present: fatigue, post-exertional malaise with a recovery period of at least 24 h, sleep dysfunction, pain, at least two neurological/neurocognitive symptoms and at least two symptoms involving the autonomic, neuroendocrine or immune system [19]
The 12 mg group demonstrated the greatest efficacy
Incretin-based medications and investigational drugs like Retatrutide are commonly associated with gastrointestinal side effects such as nausea, vomiting, diarrhea, constipation, and reduced appetite
You have a condition called multiple endocrine neoplasia syndrome type 2 (MEN 2)
Some early work has shown changes in fat-related processes
Exfoliators : Reveal smoother, brighter skin with gentle exfoliation